RITTER PHARMACEUTICALS INC (76) | Intellectual Property (3)
Browse by Subcategory
Recent Contracts
-
License Agreement with UCL Business Limited dated January 13, 2022
(Filed With SEC on March 31, 2022)
-
Exclusive License Agreement, by and between the Company and University of Louisville Research Foundation, Inc. dated as of June 9, 2020
(Filed With SEC on August 14, 2020)
-
Exclusive License Agreement, by and between Qualigen Therapeutics, Inc. and University of Louisville Research Foundation, Inc. dated as of July 17, 2020
(Filed With SEC on August 4, 2020)
